|
An analysis of the new strain of what’s being called Shanghai bird flu, conducted by Dr. Anne S. De Groot and her team of researchers at EpiVax Inc., has concluded that there may be the need to develop a new vaccine to combat a potential devastating outbreak of the disease.
more
By Richard Asinof |
|
Amgen Inc., one of the world’s biggest biotechnology companies, will spend as much as $180.5 million for the right to develop cancer drugs using nanotechnology from closely held Bind Biosciences.
more
By Elizabeth Lopatto |
|
Medical technology maker Covidien Plc. reported third quarter earnings of $453 million, or 93 cents per diluted share, a drop of 15.3 percent from the $535 million, or $1.07 per diluted share reported during the same period in 2011.
more
By PBN Staff
|
|
Biomedical Structures LLC, a developer of biomedical textiles for medical devices, has expanded its medical textile development and manufacturing facilities and appointed a new vice president of research and development, the company announced Tuesday.
more
By PBN Staff
|
|
Lifespan opened a new stem cell research laboratory Wednesday afternoon on the fifth floor of the hospital network’s Coro Building. The lab is the first phase of a major investment to turn the entire building in Providence’s Knowledge District into a state-of-the art research facility.
more
By Richard Asinof |
|
Amgen Inc., one of the world’s largest biotechnology companies, has agreed to buy genetic-testing company deCode Genetics Inc. for $415 million, Amgen announced Monday.
more
By PBN Staff
|
|
More than 470 girls from local high schools spent Thursday at the University of Rhode Island exploring STEM industries and career pathways during Tech Collective’s 12th annual GRRL Tech event.
more
By Lindsay Lorenz |
|
Pharmaceutical developer Collegium Pharmaceutical Inc. has moved its operations out of Cumberland to more refined labs Canton, Mass., the company announced Thursday.
more
By Alex Kowalski |
|
(Updated, 10:45 a.m.) A federal judge accepted Amgen Inc.’s plea agreement on a charge that it misbranded its anemia drug Aranesp, putting to rest a five-year probe of the company’s marketing practices.
more
By Christie Smythe |
|
New recipes for a vaccine to combat the H7N9 flu went into production this weekend, in a collaboration between EpiVax and Aldevron in Fargo, N.D., and a researcher at Fort Detrick, Md., the home of the Army Medical Research Institute of Infectious Diseases, according to Dr. Anne S. De Groot.
more
By Richard Asinof |